BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3493566)

  • 21. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
    Eckels DD; Sell TW; Long EO; Sekaly RP
    Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-A,B,C and DR antigens in a sample of the Tunisian population.
    Ayed K; Bardi R; Gebuhrer L; Gorgi Y; Betuel H
    Tissue Antigens; 1987 May; 29(5):225-31. PubMed ID: 3660397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of class I and class II markers on populations of leukemic cells].
    Tongio MM; Falkenrodt A; Urlacher A; Mitsuishi Y; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard X; Mayer S
    Pathol Biol (Paris); 1986 Jun; 34(6):753-7. PubMed ID: 3531991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR-linked genes are involved in the control of T lymphocyte blood levels.
    Caruso C; Modica MA; Lio D; Cillari E
    Clin Immunol Immunopathol; 1987 Aug; 44(2):160-6. PubMed ID: 3496999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
    Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective antigen presentation and novel structural properties of DR1 from an HLA haplotype associated with 21-hydroxylase deficiency.
    Davis JE; Rich RR; Van M; Le HV; Pollack MS; Cook RG
    J Clin Invest; 1987 Oct; 80(4):998-1008. PubMed ID: 2443540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.
    Nutman TB; Ottesen EA; Fauci AS; Volkman DJ
    J Clin Invest; 1984 Jun; 73(6):1754-62. PubMed ID: 6233302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease.
    Steel CM; Ludlam CA; Beatson D; Peutherer JF; Cuthbert RJ; Simmonds P; Morrison H; Jones M
    Lancet; 1988 May; 1(8596):1185-8. PubMed ID: 2897006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
    Moriya N; Sanjoh K; Yokoyama S; Hayashi T
    J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on HLA haplotypes in Jiangsu-Zhejiang-Shanghai Han population].
    Feng ML; Ji Y; Lu Q; Yang JH; Xie JH; Ji YH; Zhang GL; Yang Y
    Yi Chuan Xue Bao; 2003 Jun; 30(6):584-8. PubMed ID: 12939805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous peptides contribute to the ligand recognized by anti-DR1 human alloreactive T cells.
    Lombardi G; Sidhu S; Lamb JR; Batchelor JR; Lechler RI
    Transplant Proc; 1989 Feb; 21(1 Pt 1):142-4. PubMed ID: 2495597
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes.
    Selvaraj P; Sriram U; Mathan Kurian S; Reetha AM; Narayanan PR
    Tuberculosis (Edinb); 2001; 81(5-6):335-41. PubMed ID: 11800584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism and complexity of HLA-DR: evidence for intra-HLA-DR region crossing-over events.
    Bontrop RE; Tilanus MG; Mikulski MM; Elferink DG; Termijtelen A; de Vries RR; van Rood JJ; Giphart MJ
    Immunogenetics; 1988; 27(1):40-5. PubMed ID: 3257099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA and the role of T cells in the predisposition to disease.
    Stastny P
    Rheum Dis Clin North Am; 1987 Apr; 13(1):1-6. PubMed ID: 2442803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning.
    Schmidt AH; Baier D; Solloch UV; Stahr A; Cereb N; Wassmuth R; Ehninger G; Rutt C
    Hum Immunol; 2009 Nov; 70(11):895-902. PubMed ID: 19683023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA class I and class II polymorphism in the population of Rijeka, Croatia.
    Crnić-Martinović M; Vujaklija-Stipanović K; Ristić S; Fućak M; Kapović M; Weiner M; Sepcić J
    Coll Antropol; 2002 Jun; 26(1):69-75. PubMed ID: 12137325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of HLA linkage in a family with osteitis deformans (Paget's disease of bone).
    Breanndan Moore S; Hoffman DL
    Tissue Antigens; 1988 Feb; 31(2):69-70. PubMed ID: 3163858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of macrophages in T lymphocyte response to Candida allergen in man with special reference to HLA-D and DR.
    Nose Y; Komori K; Inouye H; Nomura K; Yamamura M; Tsuji K
    Clin Exp Immunol; 1981 Jul; 45(1):152-7. PubMed ID: 7030536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell recognized polymorphism associated with HLA-DR2 haplotypes.
    Reinsmoen NL; Bach FH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):839-41. PubMed ID: 3274879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.